SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-070696
Filing Date
2008-12-23
Accepted
2008-12-22 21:39:43
Documents
3
Period of Report
2008-12-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v135518_8k.htm 8-K 42416
2 v135518_ex10-43.htm EX-10.43 143487
3 v135518_ex10-71.htm EX-10.71 116189
  Complete submission text file 0001144204-08-070696.txt   303814
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 081265402
SIC: 2834 Pharmaceutical Preparations